| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 18 | 2020 | 48 | 3.520 |
Why?
|
| Receptors, Progesterone | 47 | 2013 | 1604 | 3.190 |
Why?
|
| Lactoferrin | 19 | 2008 | 87 | 2.600 |
Why?
|
| Progesterone | 31 | 2013 | 711 | 1.970 |
Why?
|
| Receptors, Steroid | 23 | 2018 | 337 | 1.900 |
Why?
|
| Receptors, Thyroid Hormone | 12 | 2018 | 109 | 1.770 |
Why?
|
| Mammary Glands, Animal | 22 | 2018 | 619 | 1.540 |
Why?
|
| Nerve Tissue Proteins | 15 | 2018 | 1581 | 1.420 |
Why?
|
| DNA-Binding Proteins | 25 | 2018 | 5002 | 1.240 |
Why?
|
| Reproduction | 7 | 2003 | 278 | 1.010 |
Why?
|
| Uterus | 15 | 2006 | 798 | 0.890 |
Why?
|
| Dihydroergotamine | 2 | 2020 | 11 | 0.810 |
Why?
|
| Mammary Glands, Human | 4 | 2007 | 182 | 0.760 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 491 | 0.710 |
Why?
|
| Mice, Knockout | 35 | 2018 | 5728 | 0.700 |
Why?
|
| Mammary Neoplasms, Experimental | 7 | 2018 | 550 | 0.670 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 11 | 2007 | 617 | 0.640 |
Why?
|
| Transcription Factors | 20 | 2020 | 5438 | 0.620 |
Why?
|
| Animals | 102 | 2020 | 61956 | 0.600 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 115 | 0.590 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 166 | 0.580 |
Why?
|
| Mice | 62 | 2020 | 35600 | 0.540 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2016 | 36 | 0.530 |
Why?
|
| Cell Proliferation | 8 | 2020 | 7238 | 0.530 |
Why?
|
| Dopamine | 13 | 2003 | 332 | 0.520 |
Why?
|
| Morphogenesis | 3 | 2013 | 319 | 0.520 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 1441 | 0.500 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 840 | 0.490 |
Why?
|
| Gene Expression Regulation | 19 | 2016 | 4130 | 0.490 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2020 | 7265 | 0.490 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2018 | 1367 | 0.470 |
Why?
|
| Signal Transduction | 15 | 2020 | 12103 | 0.470 |
Why?
|
| Transcriptome | 3 | 2018 | 1963 | 0.460 |
Why?
|
| Tamoxifen | 2 | 2018 | 875 | 0.460 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 9042 | 0.460 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 661 | 0.460 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 14 | 2010 | 46 | 0.410 |
Why?
|
| Ovary | 9 | 2006 | 688 | 0.410 |
Why?
|
| Transcription, Genetic | 18 | 2018 | 3339 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2018 | 2453 | 0.390 |
Why?
|
| Sexual Behavior, Animal | 6 | 2006 | 95 | 0.390 |
Why?
|
| Ovulation | 4 | 2010 | 118 | 0.380 |
Why?
|
| Receptors, Estrogen | 13 | 2018 | 2170 | 0.360 |
Why?
|
| Estradiol | 10 | 2013 | 827 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 17 | 2015 | 7100 | 0.350 |
Why?
|
| Estrogens | 11 | 2001 | 805 | 0.340 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2007 | 236 | 0.340 |
Why?
|
| Epithelium | 9 | 2013 | 782 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 3658 | 0.310 |
Why?
|
| Respiratory Burst | 1 | 2008 | 22 | 0.310 |
Why?
|
| Embryonic and Fetal Development | 2 | 1999 | 227 | 0.300 |
Why?
|
| Gene Dosage | 1 | 2011 | 823 | 0.300 |
Why?
|
| Protein Isoforms | 7 | 2003 | 848 | 0.290 |
Why?
|
| Mesencephalon | 4 | 2003 | 58 | 0.290 |
Why?
|
| Cell Movement | 4 | 2008 | 2472 | 0.280 |
Why?
|
| Progestins | 1 | 2007 | 92 | 0.270 |
Why?
|
| Iron | 6 | 2003 | 380 | 0.270 |
Why?
|
| Cloning, Molecular | 15 | 1997 | 1430 | 0.260 |
Why?
|
| Base Sequence | 22 | 2012 | 5437 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 2454 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 3917 | 0.260 |
Why?
|
| DNA | 19 | 2003 | 3050 | 0.260 |
Why?
|
| Neutrophils | 3 | 2008 | 873 | 0.250 |
Why?
|
| Recombinant Proteins | 10 | 1998 | 3028 | 0.250 |
Why?
|
| RNA, Messenger | 17 | 2016 | 6390 | 0.250 |
Why?
|
| Genitalia, Female | 2 | 2005 | 83 | 0.240 |
Why?
|
| Immunity, Mucosal | 2 | 2002 | 121 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 1642 | 0.230 |
Why?
|
| Chickens | 19 | 1993 | 783 | 0.220 |
Why?
|
| Molecular Sequence Data | 20 | 2006 | 6685 | 0.220 |
Why?
|
| Pyramidal Cells | 1 | 2004 | 172 | 0.220 |
Why?
|
| Plasmids | 8 | 2016 | 936 | 0.220 |
Why?
|
| Cell Division | 12 | 2009 | 2657 | 0.210 |
Why?
|
| Myeloproliferative Disorders | 1 | 2011 | 882 | 0.210 |
Why?
|
| Gene Expression | 9 | 2009 | 3640 | 0.210 |
Why?
|
| Breast | 4 | 2007 | 1369 | 0.200 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 993 | 0.200 |
Why?
|
| Semicircular Canals | 1 | 2002 | 21 | 0.200 |
Why?
|
| Female | 53 | 2018 | 148940 | 0.200 |
Why?
|
| Embryo Implantation | 2 | 2002 | 289 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2002 | 451 | 0.190 |
Why?
|
| Cell Survival | 3 | 2009 | 3063 | 0.190 |
Why?
|
| Dermatitis | 1 | 2001 | 61 | 0.190 |
Why?
|
| Axons | 1 | 2004 | 441 | 0.190 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2001 | 94 | 0.180 |
Why?
|
| Breast Neoplasms | 7 | 2018 | 16215 | 0.180 |
Why?
|
| Genes | 7 | 1992 | 606 | 0.180 |
Why?
|
| Humans | 53 | 2020 | 270740 | 0.170 |
Why?
|
| Cells, Cultured | 9 | 2018 | 5694 | 0.170 |
Why?
|
| Protein Binding | 8 | 2016 | 3485 | 0.170 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 98 | 0.170 |
Why?
|
| Blotting, Western | 10 | 2014 | 3584 | 0.170 |
Why?
|
| Pregnancy | 13 | 2004 | 8130 | 0.160 |
Why?
|
| Seizures | 1 | 2004 | 1001 | 0.160 |
Why?
|
| Hippocampus | 1 | 2004 | 919 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 1503 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 22 | 0.150 |
Why?
|
| Neurons | 6 | 2003 | 2439 | 0.150 |
Why?
|
| DNA Damage | 4 | 2018 | 1989 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 12 | 2009 | 3216 | 0.150 |
Why?
|
| Luteinizing Hormone | 3 | 2010 | 165 | 0.150 |
Why?
|
| Oncogenes | 2 | 2020 | 699 | 0.150 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 203 | 0.150 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 247 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2002 | 699 | 0.140 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2011 | 3156 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 1199 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2009 | 329 | 0.140 |
Why?
|
| Apoptosis | 7 | 2018 | 7757 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2003 | 1105 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2001 | 608 | 0.140 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1997 | 127 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 507 | 0.140 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 2115 | 0.130 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2016 | 50 | 0.130 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1997 | 103 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 5 | 2018 | 5759 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 896 | 0.130 |
Why?
|
| Amino Acid Sequence | 12 | 1997 | 4567 | 0.130 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2016 | 111 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 399 | 0.120 |
Why?
|
| Atherosclerosis | 3 | 2013 | 912 | 0.120 |
Why?
|
| Ovariectomy | 6 | 2006 | 371 | 0.120 |
Why?
|
| Posture | 5 | 2006 | 190 | 0.120 |
Why?
|
| Inflammation | 3 | 2018 | 2518 | 0.120 |
Why?
|
| Binding Sites | 8 | 1997 | 2255 | 0.120 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2015 | 121 | 0.120 |
Why?
|
| Mice, SCID | 1 | 2018 | 1826 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1126 | 0.110 |
Why?
|
| Disease Susceptibility | 2 | 2008 | 550 | 0.110 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2013 | 44 | 0.110 |
Why?
|
| Cytoplasmic Granules | 1 | 2014 | 87 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 160 | 0.110 |
Why?
|
| Central Nervous System | 1 | 1996 | 451 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2016 | 1655 | 0.110 |
Why?
|
| Mice, Inbred ICR | 3 | 1999 | 244 | 0.110 |
Why?
|
| Ligands | 7 | 2006 | 1012 | 0.110 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2011 | 66 | 0.110 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 841 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2016 | 701 | 0.110 |
Why?
|
| Aspergillus oryzae | 1 | 1992 | 10 | 0.100 |
Why?
|
| Mast Cells | 1 | 2014 | 229 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1993 | 662 | 0.100 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1992 | 107 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 195 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 1998 | 1110 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1149 | 0.090 |
Why?
|
| Stem Cells | 1 | 1998 | 1216 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2011 | 86 | 0.090 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2011 | 48 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2018 | 4329 | 0.090 |
Why?
|
| Thymus Gland | 2 | 2003 | 311 | 0.090 |
Why?
|
| Phenotype | 4 | 2011 | 6509 | 0.090 |
Why?
|
| Organ Specificity | 5 | 2006 | 737 | 0.090 |
Why?
|
| Pregnancy, Animal | 2 | 2001 | 102 | 0.090 |
Why?
|
| Cumulus Cells | 1 | 2010 | 44 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2196 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 42 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 2471 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 827 | 0.090 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1989 | 30 | 0.080 |
Why?
|
| Computational Biology | 1 | 2016 | 1291 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2010 | 128 | 0.080 |
Why?
|
| Ovarian Follicle | 1 | 2010 | 140 | 0.080 |
Why?
|
| Transferrin | 2 | 2003 | 76 | 0.080 |
Why?
|
| Mice, Inbred Strains | 4 | 2003 | 563 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 904 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 617 | 0.080 |
Why?
|
| Epithelial Cells | 5 | 2007 | 1875 | 0.080 |
Why?
|
| Histones | 1 | 2016 | 1513 | 0.080 |
Why?
|
| Blotting, Southern | 3 | 1992 | 453 | 0.080 |
Why?
|
| Secretory Vesicles | 1 | 2008 | 41 | 0.080 |
Why?
|
| Mifepristone | 2 | 2006 | 180 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 172 | 0.080 |
Why?
|
| Mice, Mutant Strains | 5 | 2009 | 655 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 248 | 0.070 |
Why?
|
| Chloroquine | 1 | 2007 | 63 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2000 | 3077 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 133 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1286 | 0.070 |
Why?
|
| Corpus Striatum | 2 | 2005 | 104 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 146 | 0.070 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 1049 | 0.070 |
Why?
|
| Hypothalamus | 3 | 2006 | 272 | 0.070 |
Why?
|
| Benzazepines | 2 | 2006 | 116 | 0.070 |
Why?
|
| Benzamides | 1 | 2012 | 1879 | 0.070 |
Why?
|
| Rats, Inbred WF | 6 | 2002 | 28 | 0.070 |
Why?
|
| Structure-Activity Relationship | 4 | 2005 | 979 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2008 | 292 | 0.070 |
Why?
|
| Estrous Cycle | 1 | 2006 | 40 | 0.070 |
Why?
|
| Aspergillus | 3 | 1997 | 150 | 0.070 |
Why?
|
| Consensus Sequence | 2 | 1997 | 118 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 1992 | 547 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2011 | 902 | 0.070 |
Why?
|
| Monocytes | 1 | 2010 | 790 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 1350 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2002 | 496 | 0.070 |
Why?
|
| Glycosylation | 2 | 1997 | 230 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 154 | 0.070 |
Why?
|
| Multigene Family | 4 | 1997 | 469 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1992 | 417 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 252 | 0.070 |
Why?
|
| Transfection | 10 | 2006 | 3117 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 14849 | 0.060 |
Why?
|
| Immunohistochemistry | 7 | 2006 | 7655 | 0.060 |
Why?
|
| Leukocytes | 1 | 2008 | 421 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 1996 | 3187 | 0.060 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 88 | 0.060 |
Why?
|
| Pyridines | 1 | 2012 | 1313 | 0.060 |
Why?
|
| Genes, p53 | 2 | 2007 | 1140 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 182 | 0.060 |
Why?
|
| Synovial Membrane | 2 | 2002 | 47 | 0.060 |
Why?
|
| Protein Biosynthesis | 3 | 1989 | 1028 | 0.060 |
Why?
|
| Mucins | 1 | 2006 | 289 | 0.060 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 171 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 28 | 0.060 |
Why?
|
| Kainic Acid | 1 | 2004 | 35 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2006 | 927 | 0.060 |
Why?
|
| Cell Differentiation | 3 | 2008 | 4116 | 0.060 |
Why?
|
| Alleles | 1 | 2011 | 2600 | 0.060 |
Why?
|
| Wound Healing | 1 | 2009 | 749 | 0.060 |
Why?
|
| Blast Crisis | 1 | 2007 | 588 | 0.060 |
Why?
|
| Blotting, Northern | 5 | 2001 | 726 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 562 | 0.060 |
Why?
|
| Rats | 8 | 2009 | 6441 | 0.060 |
Why?
|
| Introns | 2 | 1997 | 461 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 290 | 0.060 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 44 | 0.060 |
Why?
|
| DNA Primers | 4 | 2012 | 1496 | 0.060 |
Why?
|
| Cell Line | 9 | 1998 | 5338 | 0.050 |
Why?
|
| Heat-Shock Proteins | 3 | 1991 | 327 | 0.050 |
Why?
|
| Animals, Suckling | 1 | 2003 | 56 | 0.050 |
Why?
|
| Models, Biological | 5 | 2003 | 3194 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 3597 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2003 | 115 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2003 | 167 | 0.050 |
Why?
|
| Transcriptional Activation | 4 | 2006 | 1111 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1997 | 1076 | 0.050 |
Why?
|
| Cyclins | 2 | 2009 | 467 | 0.050 |
Why?
|
| Milk | 1 | 2003 | 128 | 0.050 |
Why?
|
| Acute Disease | 1 | 2007 | 2493 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2002 | 1584 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2003 | 1368 | 0.050 |
Why?
|
| Duodenum | 1 | 2003 | 169 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 1094 | 0.050 |
Why?
|
| Host-Parasite Interactions | 1 | 2002 | 71 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2007 | 2090 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2014 | 1563 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 658 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2015 | 1474 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2001 | 50 | 0.050 |
Why?
|
| Methylnitrosourea | 4 | 2002 | 51 | 0.050 |
Why?
|
| Colforsin | 2 | 2001 | 64 | 0.050 |
Why?
|
| Postural Balance | 1 | 2002 | 94 | 0.050 |
Why?
|
| Exons | 2 | 1997 | 1383 | 0.050 |
Why?
|
| Disease Progression | 2 | 2011 | 6867 | 0.050 |
Why?
|
| Ligases | 1 | 2000 | 81 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 252 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 768 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1999 | 7 | 0.040 |
Why?
|
| Langerhans Cells | 1 | 2000 | 53 | 0.040 |
Why?
|
| Safety | 1 | 2001 | 460 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 1903 | 0.040 |
Why?
|
| Gene Targeting | 2 | 1998 | 314 | 0.040 |
Why?
|
| Fertility | 2 | 1999 | 336 | 0.040 |
Why?
|
| Epidermis | 1 | 2000 | 196 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2002 | 220 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 1580 | 0.040 |
Why?
|
| Adenylyl Cyclases | 2 | 1997 | 103 | 0.040 |
Why?
|
| Cytokines | 2 | 2014 | 2825 | 0.040 |
Why?
|
| Adenoviridae | 3 | 2002 | 1497 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 657 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 183 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2013 | 3045 | 0.040 |
Why?
|
| Blastocyst | 1 | 1999 | 138 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1989 | 632 | 0.040 |
Why?
|
| Biotechnology | 2 | 1997 | 77 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2005 | 2098 | 0.040 |
Why?
|
| Respiratory System | 1 | 1999 | 129 | 0.040 |
Why?
|
| Intestines | 1 | 2003 | 736 | 0.040 |
Why?
|
| Response Elements | 2 | 2010 | 192 | 0.040 |
Why?
|
| Anovulation | 1 | 1997 | 5 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 631 | 0.040 |
Why?
|
| Homeostasis | 1 | 2003 | 925 | 0.040 |
Why?
|
| Uterine Diseases | 1 | 1997 | 38 | 0.040 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1997 | 21 | 0.040 |
Why?
|
| Exocrine Glands | 1 | 1997 | 15 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 1472 | 0.040 |
Why?
|
| Oviducts | 5 | 1989 | 338 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 1997 | 166 | 0.030 |
Why?
|
| Lung | 1 | 2008 | 3298 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1997 | 97 | 0.030 |
Why?
|
| Embryonic Development | 1 | 1999 | 310 | 0.030 |
Why?
|
| Male | 14 | 2015 | 128315 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1997 | 89 | 0.030 |
Why?
|
| Mutation | 5 | 2015 | 15912 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1999 | 746 | 0.030 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 1995 | 6 | 0.030 |
Why?
|
| Interleukin-1 | 3 | 2002 | 475 | 0.030 |
Why?
|
| Phytic Acid | 1 | 1995 | 11 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 367 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 1995 | 56 | 0.030 |
Why?
|
| Receptors, Dopamine | 2 | 1993 | 52 | 0.030 |
Why?
|
| Coronary Vessels | 2 | 2010 | 626 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2015 | 50 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2015 | 45 | 0.030 |
Why?
|
| Epitopes | 2 | 1988 | 707 | 0.030 |
Why?
|
| Gestational Age | 1 | 1999 | 1173 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 1995 | 161 | 0.030 |
Why?
|
| Stromal Cells | 1 | 1998 | 825 | 0.030 |
Why?
|
| Ubiquitins | 2 | 1992 | 95 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 1997 | 216 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1997 | 820 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1996 | 136 | 0.030 |
Why?
|
| Receptors, IgE | 1 | 2014 | 43 | 0.030 |
Why?
|
| Infertility, Female | 1 | 1996 | 209 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 4223 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 875 | 0.030 |
Why?
|
| Tryptases | 1 | 2014 | 47 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 600 | 0.030 |
Why?
|
| Conalbumin | 1 | 1992 | 2 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1997 | 1810 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 182 | 0.030 |
Why?
|
| Genomic Library | 1 | 1992 | 58 | 0.030 |
Why?
|
| Aspergillus nidulans | 1 | 1992 | 29 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1992 | 330 | 0.030 |
Why?
|
| Chemokines | 1 | 2014 | 290 | 0.030 |
Why?
|
| alpha-Amylases | 1 | 1992 | 15 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 1997 | 466 | 0.030 |
Why?
|
| Hyperplasia | 3 | 2001 | 564 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 1993 | 188 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 111 | 0.030 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 2002 | 128 | 0.020 |
Why?
|
| Cyclin D1 | 2 | 2009 | 589 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 631 | 0.020 |
Why?
|
| Parity | 2 | 2002 | 136 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2003 | 89 | 0.020 |
Why?
|
| Phosphorylation | 4 | 2009 | 4942 | 0.020 |
Why?
|
| Levodopa | 1 | 1992 | 94 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1997 | 1516 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 353 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2015 | 551 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1995 | 1305 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1992 | 361 | 0.020 |
Why?
|
| Ovalbumin | 1 | 1991 | 390 | 0.020 |
Why?
|
| Cattle | 1 | 1992 | 833 | 0.020 |
Why?
|
| Carcinogens | 2 | 2002 | 390 | 0.020 |
Why?
|
| Dinoprostone | 2 | 2002 | 219 | 0.020 |
Why?
|
| Steroids | 1 | 1992 | 372 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2010 | 52 | 0.020 |
Why?
|
| Age Factors | 2 | 1999 | 5457 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 14617 | 0.020 |
Why?
|
| Molecular Weight | 4 | 1992 | 721 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 123 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 968 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 2002 | 1189 | 0.020 |
Why?
|
| Cyclin D2 | 1 | 2009 | 40 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1989 | 1254 | 0.020 |
Why?
|
| Liver | 1 | 1999 | 3086 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2009 | 137 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2009 | 100 | 0.020 |
Why?
|
| Brain | 2 | 1999 | 4208 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 1563 | 0.020 |
Why?
|
| Swine | 1 | 1992 | 1607 | 0.020 |
Why?
|
| Avidin | 1 | 1987 | 23 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1997 | 1933 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 1028 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 339 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1993 | 136 | 0.020 |
Why?
|
| Serotonin | 2 | 1999 | 287 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 1996 | 1436 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2006 | 109 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 3476 | 0.020 |
Why?
|
| Myometrium | 1 | 2006 | 82 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 201 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1992 | 1624 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 879 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1986 | 263 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2005 | 56 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 117 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 437 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2006 | 158 | 0.020 |
Why?
|
| Norepinephrine | 2 | 1999 | 283 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 413 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2005 | 198 | 0.020 |
Why?
|
| Quinpirole | 2 | 1997 | 6 | 0.020 |
Why?
|
| Species Specificity | 1 | 1986 | 794 | 0.020 |
Why?
|
| Methamphetamine | 1 | 2005 | 61 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 670 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 2137 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 1456 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2006 | 518 | 0.010 |
Why?
|
| Disease Models, Animal | 3 | 2003 | 7381 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1988 | 4481 | 0.010 |
Why?
|
| alpha-Synuclein | 1 | 2005 | 118 | 0.010 |
Why?
|
| Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 1 | 0.010 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2003 | 16 | 0.010 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2003 | 15 | 0.010 |
Why?
|
| Homozygote | 2 | 1996 | 772 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 669 | 0.010 |
Why?
|
| Chimera | 2 | 1995 | 152 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 379 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2010 | 2441 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 622 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 3438 | 0.010 |
Why?
|
| Reproductive History | 1 | 2001 | 23 | 0.010 |
Why?
|
| Perphenazine | 1 | 2001 | 6 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 885 | 0.010 |
Why?
|
| Ergolines | 2 | 1991 | 8 | 0.010 |
Why?
|
| Ethers, Cyclic | 2 | 1991 | 19 | 0.010 |
Why?
|
| Okadaic Acid | 2 | 1991 | 31 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 274 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 169 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 194 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2001 | 129 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 223 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2001 | 115 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 2001 | 93 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 255 | 0.010 |
Why?
|
| Oxazolone | 1 | 2000 | 5 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2001 | 33737 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2001 | 347 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1991 | 257 | 0.010 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1999 | 19 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1999 | 35 | 0.010 |
Why?
|
| Knee Joint | 1 | 2001 | 166 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 1999 | 41 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 1999 | 35 | 0.010 |
Why?
|
| Precipitin Tests | 2 | 1991 | 350 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 401 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1999 | 17 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 1999 | 174 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 1121 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 99 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1991 | 1697 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2000 | 211 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1542 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1999 | 151 | 0.010 |
Why?
|
| Cell Count | 1 | 1999 | 512 | 0.010 |
Why?
|
| Diethylstilbestrol | 2 | 1989 | 165 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 1125 | 0.010 |
Why?
|
| Allergens | 1 | 2000 | 252 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 1997 | 1857 | 0.010 |
Why?
|
| Organ Size | 1 | 1999 | 692 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1999 | 279 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 204 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 485 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1999 | 335 | 0.010 |
Why?
|
| Carbachol | 1 | 1997 | 33 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 1133 | 0.010 |
Why?
|
| DNA Replication | 1 | 2001 | 770 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 1997 | 42 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 169 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1997 | 151 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1997 | 224 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1997 | 67 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 1999 | 531 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 169 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 2156 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1997 | 125 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 329 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 240 | 0.010 |
Why?
|
| Endometritis | 1 | 1996 | 11 | 0.010 |
Why?
|
| Copulation | 1 | 1995 | 13 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 1996 | 72 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 1253 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 2422 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 326 | 0.010 |
Why?
|
| Decidua | 1 | 1995 | 152 | 0.010 |
Why?
|
| Skin | 1 | 2000 | 1271 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 1991 | 2357 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1999 | 1418 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 909 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 225 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5408 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1993 | 41 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1992 | 66 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 1424 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1995 | 425 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1996 | 605 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1992 | 128 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 938 | 0.010 |
Why?
|
| Coturnix | 1 | 1991 | 9 | 0.010 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1991 | 39 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 5824 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1991 | 134 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1991 | 34 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1997 | 705 | 0.010 |
Why?
|
| Epinephrine | 1 | 1991 | 239 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1993 | 1685 | 0.010 |
Why?
|
| Solubility | 1 | 1990 | 247 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 13006 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 5149 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1992 | 310 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 1942 | 0.010 |
Why?
|
| Action Potentials | 1 | 1992 | 588 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1993 | 809 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1989 | 159 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1989 | 60 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1992 | 878 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 5056 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1993 | 1138 | 0.000 |
Why?
|
| Cosmids | 1 | 1987 | 58 | 0.000 |
Why?
|
| RNA Caps | 1 | 1987 | 40 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1992 | 527 | 0.000 |
Why?
|
| Hybrid Cells | 1 | 1987 | 148 | 0.000 |
Why?
|
| Metaphase | 1 | 1987 | 124 | 0.000 |
Why?
|
| Rabbits | 1 | 1989 | 1028 | 0.000 |
Why?
|
| Oncogene Proteins v-erbA | 1 | 1987 | 7 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 161 | 0.000 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 24 | 0.000 |
Why?
|
| Cell Line, Transformed | 1 | 1987 | 427 | 0.000 |
Why?
|
| Cricetulus | 1 | 1987 | 214 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 3949 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 161 | 0.000 |
Why?
|
| Trypsin | 1 | 1986 | 156 | 0.000 |
Why?
|
| Cricetinae | 1 | 1987 | 769 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1987 | 895 | 0.000 |
Why?
|
| Risk Factors | 1 | 2001 | 17888 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 7914 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1986 | 1309 | 0.000 |
Why?
|